SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010151
Filing Date
2021-08-04
Accepted
2021-08-04 13:01:22
Documents
79
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20210630x10q.htm   iXBRL 10-Q 2536124
2 EX-10.4 clvs-20210630xex10d4.htm EX-10.4 171792
3 EX-10.44 clvs-20210630xex10d44.htm EX-10.44 118506
4 EX-31.1 clvs-20210630xex31d1.htm EX-31.1 15693
5 EX-31.2 clvs-20210630xex31d2.htm EX-31.2 15888
6 EX-32.1 clvs-20210630xex32d1.htm EX-32.1 6433
7 EX-32.2 clvs-20210630xex32d2.htm EX-32.2 6507
  Complete submission text file 0001558370-21-010151.txt   10284340

Data Files

Seq Description Document Type Size
8 EX-101.SCH clvs-20210630.xsd EX-101.SCH 52496
9 EX-101.CAL clvs-20210630_cal.xml EX-101.CAL 69488
10 EX-101.DEF clvs-20210630_def.xml EX-101.DEF 187603
11 EX-101.LAB clvs-20210630_lab.xml EX-101.LAB 492407
12 EX-101.PRE clvs-20210630_pre.xml EX-101.PRE 354635
13 EXTRACTED XBRL INSTANCE DOCUMENT clvs-20210630x10q_htm.xml XML 2189159
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 211143243
SIC: 2834 Pharmaceutical Preparations